https://www.selleckchem.com/products/sar7334.html
BACKGROUND Brain metastases (BM) cause symptoms that supportive medications can alleviate. We assessed whether racial disparities in supportive medication utilization after BM diagnosis exist. METHODS SEER-linked, Medicare-enrolled patients diagnosed with BM between 2007-2016 were identified. Fourteen supportive medication classes were studied non-opioid analgesics, opioids, antiemetics, antiepileptics, headache-targeting medications, steroids, cognitive aids, antidepressants, anxiolytics, anti-delirium/antipsychotic agents, muscle rela
Gefällt mir
Kommentar
Teilen
